Similar Papers

Paper Title
Journal
Date
Author
Erlotinib-related skin toxicities: Treatment strategies in patients with metastatic non-small cell lung cancer
Yoshio Kiyohara ... Akiko Kishi
Journal of the American Academy of Dermatology | VOL. 69
Yoshio Kiyohara, et. al.Yoshio Kiyohara ... Akiko Kishi
17 Apr 2013
Abstract LB-170: Preliminary report of a phase I/II trial to assess safety and tolerability of an oral Aurora kinase A inhibitor, MLN 8237 (alisertib), in combination with erlotinib in patients with recurrent or metastatic non-small cell lung cancer (NSCLC).
Hossein Borghaei ... Samuel Litwin
Cancer Research | VOL. 73
Hossein Borghaei, et. al.Hossein Borghaei ... Samuel Litwin
15 Apr 2013
Meta-Analysis of EGFR Kinase Inhibitors: Not Always Greater Than the Sum of Its Parts
S Cardarella ... B E Johnson
JNCI Journal of the National Cancer Institute | VOL. 105
S Cardarella, et. al.S Cardarella ... B E Johnson
17 Apr 2013
AB036. Comparison of the effectiveness of gefitinib, erlotinib and afatinib in epidermal growth factor receptor mutated tumors of non-small cell lung cancer
Maria Papathanasiou ... Paulos Zarogoulidis
Annals of Translational Medicine | VOL. 4
Maria Papathanasiou, et. al.Maria Papathanasiou ... Paulos Zarogoulidis
01 Nov 2016
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Supervised Exercise for Patients With Metastatic Breast Cancer: A Cost-Utility Analysis Alongside the PREFERABLE-EFFECT Randomized Controlled Trial
Aniek E.M Schouten ... Anne M May
Journal of Clinical Oncology | VOL. -
Aniek E.M Schouten, et. al.Aniek E.M Schouten ... Anne M May
13 Jan 2025
Targeting CD30 in Diffuse Large B-Cell Lymphoma: Where Does It Fit in?
Jennifer L Crombie ... Ann S Lacasce
Journal of Clinical Oncology | VOL. -
Jennifer L Crombie, et. al.Jennifer L Crombie ... Ann S Lacasce
07 Jan 2025
Should Total Neoadjuvant Therapy Be the First-Line Treatment for Patients With Locally Advanced Rectal Cancer?
Mahsoem Ali ... Geert Kazemier
Journal of Clinical Oncology | VOL. -
Mahsoem Ali, et. al.Mahsoem Ali ... Geert Kazemier
06 Jan 2025
Datopotamab Deruxtecan in Advanced or Metastatic Non–Small Cell Lung Cancer With Actionable Genomic Alterations: Results From the Phase II TROPION-Lung05 Study
Jacob Sands ... Luis Paz-Ares
Journal of Clinical Oncology | VOL. -
Jacob Sands, et. al.Jacob Sands ... Luis Paz-Ares
06 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.